silybin has been researched along with Salivary Gland Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, NP; Cho, SD; Choi, ES; Hong, SD; Jang, B; Kwon, HJ; Oh, S; Shin, JA; Won, DH; Yang, IH; Yu, HJ | 1 |
1 other study(ies) available for silybin and Salivary Gland Neoplasms
| Article | Year |
|---|---|
Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.
Topics: Antioxidants; Apoptosis; Bcl-2-Like Protein 11; Cell Cycle; Cell Line, Tumor; Humans; MAP Kinase Signaling System; Salivary Gland Neoplasms; Silybin; Silymarin | 2017 |